Dr. Drew Pinsky warns on ibogaine in addiction treatment

The recent death of Presley Gerber, the 27-year-old son of Cindy Crawford, at a California rehab facility has sparked discussions on the effectiveness and safety of addiction treatments. According to Dr. Drew Pinsky, an addiction specialist, Gerber's case underscores the potential dangers of allowing patients to dictate their own treatment plans, particularly when involving unapproved substances like ibogaine.

Concerns Over Ibogaine Use

Dr. Drew Pinsky expressed concern on his "Ask Dr. Drew" podcast about Gerber's self-reported use of ibogaine, a psychoactive compound derived from an African shrub. Ibogaine has been studied as a potential treatment for substance use disorders but remains unapproved by the FDA due to risks, including fatal heart arrhythmias, as noted by federal health agencies. Pinsky highlighted that many patients who have tried ibogaine or similar substances like ayahuasca often relapse and may experience personality changes.

The Risks of Self-Directed Care

Pinsky criticized the trend of allowing patients to determine their own care, stating that it can lead to poor outcomes. He emphasized that even high-end rehab centers cannot guarantee recovery from severe opioid dependence without adhering to evidence-based, FDA-approved treatments. Dr. Nicholas Kardaris, CEO of the New York Center for Living, echoed these concerns, noting that the period immediately following rehab is particularly dangerous for patients.

Why It Matters

The case of Presley Gerber highlights the ongoing debate over the use of alternative therapies in addiction treatment. With opioid addiction having a worse prognosis than many cancers, according to Pinsky, the need for reliable, evidence-based treatment is critical. Families are urged to seek fully licensed facilities that offer FDA-approved medications like buprenorphine, methadone, and naltrexone.

Presley Gerber's death serves as a cautionary tale about the complexities of addiction treatment and the importance of adhering to medically approved protocols.